OncoSil Medical
@OncoSil
Followers
1,046
Following
178
Media
89
Statuses
131
(ASX: $OSL) is a global medical device company focused on Interventional Oncology.
Sydney, New South Wales
Joined July 2018
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Iran
• 361146 Tweets
jeonghan
• 253891 Tweets
Quito
• 154759 Tweets
Alex Jones
• 116695 Tweets
Harris 2024
• 102404 Tweets
The Next Prince Q7
• 86703 Tweets
Rey de España
• 73452 Tweets
Bobrisky
• 62212 Tweets
Hurricane Helene
• 49618 Tweets
Vince
• 35246 Tweets
50 Cent
• 31967 Tweets
Falz
• 28048 Tweets
Coke
• 25298 Tweets
Ubisoft
• 24884 Tweets
UNLV
• 23881 Tweets
Sluka
• 22840 Tweets
Twente
• 20309 Tweets
#BINIDocuBornToWinOniWantTFC
• 19910 Tweets
Porto
• 18887 Tweets
Bolton
• 17474 Tweets
#السوبر_مع_فايق
• 16546 Tweets
Getafe
• 15644 Tweets
Ciro
• 15180 Tweets
Eilat
• 13198 Tweets
Epigmenio
• 12938 Tweets
Nabi
• 11746 Tweets
Kaizer Chiefs
• 11703 Tweets
Assassin's Creed Shadows
• 10912 Tweets
Happy Birthday Mark
• 10077 Tweets
We thought it was important for you to get to know the people behind the logo. As we launch our
#WeAreOncosil
series, over the next 8 weeks, you will meet and get to know the team from different parts of the business.
#WeAreOncosil
,
#gettoknowus
,
#getinspired
16
18
27
The OSPREY Patient Registry been developed to collect data and assess the performance and safety of the OncoSil™ device when used within the approved indication. This post is for healthcare professionals only.
Learn More: link to
11
19
24
Learn more about the symptoms of pancreatic cancer here:
#WorldPancreaticCancerAwarenessMonth
15
20
23
Only 1 week to go! Don’t miss our Symposium on Downstaging Unresectable LAPC, Discussion on the Resection Data from the PanCO Study.
#EAHPBA
,
#VirtualCongress
,
#OncoSil
,
#PanCOstudy
8
15
24
5
16
20
Last week, our European team came together and met in Munich for the first time. It was exciting to have such knowledge and expertise working together on how to further our company mission .
#WeAreOncoSil
,
#TeamWork
,
#FaceToFaceMeeting
,
#GettingItDone
11
18
21
We are excited to be participating in our first UK Virtual Congress
@BNMS
. Come say hello and chat with one of our team!
#BNMS
,
#NuclearMedicine
,
#VirtualMeeting
,
#OncoSil
11
18
21
#Coffee
,
#CancerSupport
,
#Worldsbiggestcoffeemorning
,
#MacmillanCancer
,
#OncoSil
,
#Donate
If you would like to show your support, please click on this link:
5
14
18
This post is intended for healthcare professionals only
#Research
,
#ClinicalDevelopment
,
#OncoSil
,
#GetInTouch
6
14
15
Our team is currently attending the
@PancreaticCanUK
Virtual Annual Summit 2020. By attending and supporting this Summit, we hope we can contribute to find innovative solutions to assist in
#transformingtheprognosis
. Find out more about
#SummitPanc20
:
0
1
10
Success! It was great to be back in London to do some face-to-face filming with Dr Zarni Win about his experience using the OncoSil™ technology and the future of Nuclear Medicine
#BNMS
,
#EANM
,
#TheLondonClinic
0
3
10
#Pancreaticcancer
is often diagnosed late and progresses so quickly it’s a cancer emergency. According to research by
@PancreaticCanUK
, 7 in 10 people with pancreatic cancer do not receive any active treatment
0
10
9
At OncoSil Medical we are committed to
#transformingtheprognosis
. Learn more about our mission in our video 👉
0
5
9
We are proud to announce OncoSil Medical has achieved its first sale in New Zealand, “an important milestone for OncoSil Medical as we begin transforming ourselves into a global commercial-stage medical device company.” commented CEO Daniel Kenny.
0
1
8
OncoSil Medical (ASX: $OSL) new Chief Executive Officer and Managing Director, Nigel Lange, comments its recent appointment: “I am excited by the opportunity to lead OncoSil Medical as it transitions into a commercial-stage medical device company”
0
4
7
We are very proud of the training kit we developed for the people who prepare and deliver OncoSilᵀᴹ suspension. This kit forms part of OncoSil Medical Training Programme, a mandatory step for all those involved in the implantation process.
0
5
7
We are pleased to announce the appointment of David Turner as Global Head of Medical Affairs. David has over 40 years’ experience in the pharmaceutical, medical device and health technology industries:
0
3
6
$OSL | Today we have filed for
#TGA
registration for our lead device, OncoSil™, for the treatment of locally advanced
#pancreaticcancer
in combination with chemotherapy. Take a look:
#medtech
#oncology
#transformingtheprognosis
0
2
5
OncoSil Medical (ASX: $OSL) is pleased to announce that it has received regulatory approval for its OncoSil™ System in Switzerland. This approval means OncoSil Medical is able to market OncoSil™ System in Switzerland.
0
1
6
Congratulations
@thelondonclinic
for being UK’s first independent hospital to introduce OncoSilᵀᴹ
0
5
7
The OncoSil Medical UK team is growing! We are glad to welcome Rachel Duggan, Regional Head UK & Ireland and Andy Ferrie, Account Manager UK.
0
0
7
We are proud to be a primary partner of the
#IHPBA2020
World Congress. In support of the meeting, we will host a webinar on Saturday 28 presented by Hepatobiliary and Pancreatic surgeon Daniel Croagh and medical oncologist Harpreet Wasan. Register:
@IHPBA
0
2
7
It’s Belgian Surgical Week 2021! Feels great to be in Antwerp attending this meeting in person. Looking forward to hearing some great talks over the next couple of days.
#RBSS
,
#BSW2021_be
,
#OncoSil
,
#HPBsurgeon
,
#TransplantSurgeon
0
2
6
Today, starts the
#IHPBA2020
World Congress gathering over 4000 delegates from all over the world. We are looking forward to hearing Doctors Daniel Croagh & Harpreet Wasan’s webinar about OncoSil™. The presentation will be available soon. Stay tuned!
@IHPBA
0
2
6
We welcome Dr Ralph Peters as our Chief Medical Officer. Dr Peters brings with him over 30 years’ experience in the field of interventional radiology. Learn more:
0
0
5
We are pleased to announce the appointment of Henk Tissing as Director, Global Clinical Affairs. Henk will be responsible for the execution of the clinical development program.
0
1
5
Most people wouldn’t know where their pancreas is located, but what they should know is how to identify potential symptoms of
#pancreaticcancer
– one of the deadliest of all cancers. This article highlights 6 signs of the deadly disease:
0
1
5
Throughout November, we join the World Pancreatic Cancer Coalition’s initiative
@worldpcc
to help raise awareness for the fight against this insidious cancer.
#WPCD
#ItsAboutTime
Spread the word!
0
0
5
Today we are excited to launch our newly designed website. We have developed a website that reflects our new branding as well as our business and commitment to
#transformingtheprognosis
. Feel free to have a look 👉
0
1
4
Thursday 4 February is
#WorldCancerDay
– there isn’t a better day to remind ourselves what cancer is. Find out more about the disease here:
0
5
5
We welcome Antonio Ponce Cuesta as OncoSil Medical’s Regional Head of Spain & Portugal. Antonio has 20 years´ experience in the Pharmaceutical and Medical Devices industries providing support in Surgery, Oncology, Gastroenterology, Interventional Radiology and Nuclear Medicine.
0
1
5
Today we welcome Nigel Lange, former Group Chief Commercial Officer of Sirtex as our EMEA President. He brings a wealth of experience & success commercialising medical devices with similar attributes to the $OSL device. Read more:
#pancreaticcancer
0
2
4
$OSL | Leading
@Bell_Potter
healthcare analyst, John Hester, has identified OncoSil Medical (ASX:OSL) as a top stock pick for this financial year. Read the full report 👉
#medtech
#oncology
#transformingtheprognosis
#pancreaticcancer
1
2
3
80% of those diagnosed with
#pancreaticcancer
die within a year, according to
@PancreaticCanUK
. With limited treatment options available, OncoSil Medical (
#ASX
: $OSL) is confident as we progress towards commercialisation of our
#medicaldevice
#OncoSil
™ System
0
0
4
The OncoSil™ device has been studied in multiple indications across several different geographies. These studies are providing us and the healthcare community essential insights.
0
2
4
$OSL The investment advisory group Wilsons has published an Equity Research Alert about OncoSil Medical. Please take a look here:
0
1
4
Every day, more than 1,200 people worldwide are diagnosed with pancreatic cancer. Today is World Pancreatic Cancer Day, a day where people around the world unit to
#demandbetter
in the fight against one of the world’s toughest cancer. Read more:
0
1
4
As part of the World Pancreatic Cancer Day 2020,
#ItsAboutTime
to know the symptoms of the disease. Take two minutes to watch this video and share it with your community to raise awareness.
#WPCD
0
2
4
The OncoSil™ treatment involves a multi-disciplinary team. Nuclear medicine personnel, oncologists, radiologists, endoscopists and procedural staff: they all take part in the OncoSil™ journey to the patient.
0
4
4
2021 promises to be an exciting year for OncoSil Medical as we have entered a new phase of commercialising the OncoSil™ System. For this new year, our resolution is unchanged: we will keep working toward
#transformingtheprognosis
0
0
4
Project Purple,
@Run4Purple
, has a great podcast series which covers
#pancreaticcancer
topics, and even includes episodes related to
#COVID19
and pancreatic cancer. Well worth a listen:
1
1
3
⭐️ OncoSil receives regulatory approval in Malaysia⭐️
OncoSil Medical Ltd is pleased to announce that it has received regulatory approval from the Medical Device Authority of Malaysia for the OncoSil™ System.
Take a look 👉
#transformingtheprognosis
1
1
3
The development of OncoSil™ is the result of over 15 years of hard work involving many individuals committed to
#transformingtheprognosis
. Learn more about our history:
0
0
3
In case you missed it, our CEO presented at the recent
@Finnewsnetwork
Virtual CEO event. Watch the full presentation here: $OSL
#ASX
0
2
2
For
#WorldCancerDay
, we would like to bring to light the little change in pancreatic cancer survival in the last 40 years. Let’s keep working toward
#transformingtheprognosis
.
0
1
3
“Maintaining a healthy weight and making physical activity part of your everyday life can help reduce your risk of ten cancers” which include pancreatic cancer, says
@uicc
#WorldCancerDay
0
2
3
Join our OncoSil UK team at
@PancreaticCanUK
Virtual Annual Summit 2020: Improving Outcomes Now, starting on 17th September
#SummitPanc20
Book your place:
0
1
3
“Dedicated to transforming the prognosis”: our tagline represents our mission to do better for patients and their families living with unmet medical needs.
#transformingtheprognosis
0
0
3
As part of
#WorldHealthDay
, we would like to raise awareness about the role of healthy lifestyle choices in the prevention of cancer. Smoking, drinking alcohol and poor diet are some factors which can increase the chance of developing pancreatic cancer.
0
2
3
For many people with pancreatic cancer and their families, the coronavirus is an extra cause for concern.
@PancreaticCanUK
provides useful information on how the pandemic is affecting treatment and care for pancreatic cancer:
1
0
2
Bell Potter releases updated report on $OSL following IQVIA appointment, looking at our company’s recent clinical data – see link here:
0
0
3
OncoSil Medical’s global headquarters and the Australian team have a new address. We are now located at Suite 503, 15 Blue Street in North Sydney.
0
0
3
On 11/09, we joined 227 clinicians, scientists and charity rep at the
#2020LPW
to discuss a wide range of topics, including the significance of clinical trials. At OncoSil, research is an essential step in our commitment to
#transformingtheprognosis
.
0
1
3
An insightful podcast series for people who are living with advanced cancer and those who care for them – The Thing About Advanced Cancer:
0
0
3
$OSL OncoSil Medical is pleased to provide an update regarding the resected cohort of patients enrolled in the PanCO clinical trial. The clinical trial has produced positive results to date as 10 out of 42 patients were able to undergo surgical resection.
0
0
2
Great presentation led by Mr Daniel Croagh & Dr Harpreet Wasan at the
#IHPBA2020
Virtual Congress last week. The recording is available on request for Healthcare Professionals. Contact us:
0
1
3
Keep up with what is happening at OncoSil Medical by following us on LinkedIn. Our social media platforms are a great way to be connected in real time as our major news unfolds and to follow our progress towards
#transformingtheprognosis
. Connect with us:
0
2
3
Our CEO recently spoke with
@Finnewsnetwork
journalist
@OrtenziaBorre
on what our CE Marking means and the next steps as we move to commercialise our OncoSil™ device for
#pancreaticcancer
#ASX
0
1
2
By 2030 the
@aihw
predicts that
#PancreaticCancer
cancer will be the second highest cause of cancer mortality, and yet it is still considered a rare and neglected cancer. Listen here to learn more about this terrible disease and why it is so hard to treat:
0
2
2
We have the pleasure to share OncoSil Medical Chairman’s Address for the 2020 Annual General Meeting taking place today. Read Dr Chris Roberts’ speech:
0
0
2
OncoSil Medical is excited to launch a Chinese language website, acknowledging the company’s growing Chinese shareholder base and importance of the China market to the company’s future commercialization plans:
0
1
2
Compared with many other cancers, the survival rate for pancreatic cancer is very low.
0
1
2
Researchers at Rush University Medical Center (Chicago, USA) have found that opioid use may increase risk of developing pancreatic cancer. Learn more:
0
1
2
@letswinpc
is hosting “Let’s Learn”, a series of educational webinars for health care professionals about the risks, symptoms, and treatments of pancreatic cancer. Learn more:
1
1
2
@RachelDuggan
was spotted out in Newcastle (UK) interviewing healthcare practitioners. Thank you to
@DerekManas
for sharing your thoughts with us on resectability in pancreatic cancer.
#TransplantSurgeon
,
#HPBsurgeon
,
#TheFreemanHospital
,
#AUGIS
,
#GBIHPBA
,
#PancreaticCancer
0
1
2
$OSL |
#OncoSil
Medical has today announced it has received approval for the marketing and sale of its OncoSil™ device in Singapore – which follows European CE Marking and designation as a ‘breakthrough device’ in April:
#medtech
#transformingtheprognosis
0
1
1
Thank you
@BiotechDaily
for covering the news of our CE Marking approval and noting the OncoSil™ device has received breakthrough designation for
#pancreaticcancer
. Read more here:
#ASX
#biotech
$OSL
0
3
2
We are very proud to working hard and play a part towards making this a reality for
#pancreaticcancer
patients.
#ASX
$OSL
#Biotech
#AusBiz
This
#GivingTuesday
we're sharing our vision, a world where everyone with
#pancreaticcancer
survives to live long and well. We believe it is possible, breakthroughs *do* happen - and we're going to do it *together*. Please Retweet and Give if you can 💜
0
20
23
0
0
2
#ASX
& finance news publication
@themarketherald
reported on our latest regulatory milestone as the OncoSil™ device received CE Marking approval. This means the breakthrough device can be sold & marketed in the EU & UK. Read the full story here: $OSL
0
1
1
Our CEO Daniel Kenny invites OncoSil Medical’s ($OSL) shareholders to the 2020 AGM today. A great opportunity for investors to hear of the past year achievements and planned upcoming activities. The presentation can be viewed here:
0
1
2
In case you missed it: following our CE Marking approval for the OncoSil™ device, we filed for registration approval in key ASEAN & APAC markets, incl. Singapore, HK & Malaysia. Read more here:
0
0
1
Last week, our CEO
@danwkenny
spoke with
@CommSec
’s Tom Piotrowski about the company’s technology, market opportunity, outlook for
the coming months and investment trends in Australian healthcare. View the
video here:
#medicaldevice
#Biotech
#ASX
$OSL
0
0
2
“Each day in the U.S., an estimated 155 Americans will be diagnosed with pancreatic cancer and an estimated 125 Americans will die of pancreatic cancer” - sobering statistics from
@TheConversationUS
detailing why this disease is so hard to detect and treat
0
1
2
OncoSil ($ASX:
#OSL
) is proud to have successfully implanted 42
#pancreatic
cancer patients with the OncoSil™ device.
Below an interesting read on how clinical trials can benefit patients as well as advancement in disease treatment:
0
0
2
We would like to invite healthcare professionals to join us on September 17th (13:50 CET) when we will be attending the E-AHPBA virtual congress. Listen to what experts have to say on the latest resection data from the PanCO study.
Link:
0
2
2
The OncoSil Medical team is taking a holiday. We will be back to work on the 4th of January. Happy holidays, enjoy the festive season and see you in 2021!
0
1
1
OncoSil (
#ASX
: $OSL) is a
#medicaldevices
company focused on a treatment for
#pancreaticcancer
patients. Our device
#OncoSil
™ is progressing toward commercialisation and is currently undergoing
#clinicaltrials
at leading sites globally. Follow us here:
@OncoSil
#Biotech
#AusBiz
0
1
1
A retrospective study using electronic health records was undertaken to determine if individuals at high risk of pancreatic cancer could be identified early in the disease stage. Read the article from European Journal of Cancer:
0
0
1
#Pancreaticcancer
’s exact cause isn’t well understood.
@PanCAN
answers some common questions about the disease in this helpful article:
0
1
1
OncoSil Medical is supporting
#WorldCancerDay
on February 4th. This initiative is led by
@uicc
to raise worldwide awareness, improve education and encourage action. Join us to make a difference!
#WCD2021
0
2
1
In case you missed it
@SmallCapsASX
covered our CE Marking achievement and breakthrough designation for our OncoSil™ device for
#pancreaticcancer
.
#ASX
#Biotech
$OSL Read more:
0
2
1
According to American Cancer Society, overall US cancer deaths have declined, however liver and pancreatic cancer continue to climb. With limited treatment options available, OncoSil (
#ASX
: $OSL) is excited about the impact our
#medicaldevice
can make.
0
1
1
Lifestyle changes are imperative to minimising risks of
#pancreaticcancer
Obesity contributes to poorer prognosis and survival rates in pancreatic cancer patients. Share our GIF to improve awareness of lifestyle changes that can reduce the risk of pancreatic cancer
@PCE_Association
#WPCD
#PancreaticCancer
0
7
7
0
0
1
Did you know that without action
#pancreaticcancer
is likely to become Australia’s second biggest cancer killer?
@AvnerFoundation
is calling for an urgent national response, read their in-depth report here:
0
0
1